The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled clinical trial-Reference-Cited by-同舟云学术

The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled clinical trial

Published:2019-07-10 Issue:9 Volume:33 Page:2369-2377
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Darand Mina¹,Darabi Zahra¹,Yari Zahra¹,Hedayati Mehdi²,Shahrbaf Mohammad Amin¹,Khoncheh Ahmad³,Hosseini‐Ahangar Behnam³,Alavian Seyed Moayyed³,Hekmatdoost Azita¹^ORCID

Affiliation:

1. Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research InstituteShahid Beheshti University of Medical Sciences Tehran Iran

2. Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine SciencesShahid Beheshti University of Medical Sciences Tehran Iran

3. Baqiyatallah Research Center for Gastroenterology and Liver DiseasesBaqiyatallah University of Medical Sciences Tehran Iran

Funder

Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.6424

Reference42 articles.

1. Validation of a New Self-Report Instrument for Measuring Physical Activity

2. REGULATION OF APOLIPOPROTEIN A-1 AND APOLIPOPROTEIN B100 GENES BY THYMOQUINONE RICH FRACTION AND THYMOQUINONE IN HEPG2 CELLS